Nanobots are one of the recent nanotechnologies. These bots are about 50-100nm wide and carry out specific functions as instructed. Nanobots are used effectively to deliver drugs. They work through the body to detect the area affected by a disease (Bhore, 2016). The new technology improves healthcare because nanobots can detect tumors and deliver drugs easily, conveniently within a short time. Another advantage of nanobots is that they can be tailored towards the needs and preferences of the patient (Huston, 2021). Due to their multifunctional nature, nanobots can be used to enhance the quality of care. In terms of cost, the bots are cost-friendly in comparison with the services they offer. Insurers also reimburse hospitals for the technology, making it cost-effective.
Nanobots impact healthcare and nursing practice because nurses must conduct molecular profiling and develop routines based on molecules. Molecular profiling has been advantageous because it helps identify specific tumors that would otherwise not be identified under normal circumstances. However, the technology is also associated with barriers such as potential danger to the environment and humans, loss of jobs because the bots replace human labor, and economic market crashes (McGuiness et al., 2019). Stakeholders can enhance the implementation of nanobots by integrating their use with human labor to minimize job loss. It is also important to review its manufacturing to prevent harm to people and the environment.
Bhore, P. R. (2016). A survey on nanorobotics technology. International Journal of Computer Science & Engineering Technology, 7(9), 415-422.
Huston, C. (2021). Emerging Technologies in Healthcare: Challenges and Opportunities.
edu/cgi/viewcontent.cgi?article=1048&context=loyola_palmerresearchsymposium”>https://ecommons.luc.edu/cgi/viewcontent.cgi?article=1048&context=loyola_palmerresearchsymposium (Links to an external site.)
McGuiness, D. T., Selis, V., & Marshall, A. (2019). Molecular-based nano-communication network: A ring topology nanobots for in-vivo drug delivery systems. IEEE Access, 7, 12901-12913.
org/stamp/stamp.jsp?arnumber=8618321″>https://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=8618321 (Links to an external site.)
I NEED TO ANSWER THIS DISCUSSION BOARD WITH AT LEAST 2 PARAGRAPHS AND USE 3 SOURCES NO LATER THAN 5 YEARS